Read Scott like a free app: tap then Add to Home Screen. Read Scott like a free app: tap then Add app to Home screen. Add Read Scott Alexander to your home screen to read it like an app.
Want to dive into Scott Alexander's work and his thousands of blog posts? This fan website lets you sort and do semantic search through the whole codex. Enjoy!
| Date | ||
| Length | ||
| Likes | ||
| Comments |
Scott Alexander corrects and expands on the story of Omegaven, a life-saving infant nutritional fluid, using it to illustrate systemic issues with medical regulation and drug approval.
Scott Alexander argues that the FDA is too strict, not too lax, and proposes unbundling FDA approval to allow for more nuanced drug regulation.
Scott Alexander argues that the 33% rate of post-marketing safety events for FDA-approved drugs is not necessarily concerning and explains why post-marketing surveillance is a normal part of drug safety monitoring.
Scott Alexander drafts a letter to the FDA arguing against their decision to halt 23andMe's genetic testing services, highlighting the benefits and addressing the FDA's concerns.
Read Scott like a free app: tap then Add to Home Screen. Read Scott like a free app: tap then Add app to Home screen. Add Read Scott Alexander to your home screen to read it like an app.